Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60760-882

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

882-30 (Atorvastatin 60760 882 30)

Label for Atorvastatin Calcium 40 mg film-coated tablets, USP, with a quantity of 30 tablets. The label includes the National Drug Code (NDC) 60760-882-30 and notes the product is packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ, and manufactured by Annora Pharma Pvt. Ltd, Telangana, India. Storage instructions specify controlled room temperature (15°-30°C).*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, including two atorvastatin molecules complexed with one calcium ion and three water molecules, depicted with chemical bonds and groups such as hydroxyl, carboxyl, and fluorophenyl.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph comparing the cumulative incidence percentage over approximately 3.5 years for Atorvastatin versus placebo. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage, with Atorvastatin consistently showing lower incidence than placebo throughout the period.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph showing cumulative hazard percentages over time in years for two groups: Atorvastatin and Placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a lower cumulative hazard compared to placebo. A hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and p-value of 0.001 is indicated.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph comparing the time to first major cardiovascular endpoint (in years) for Atorvastatin 10 mg and Atorvastatin 80 mg. The y-axis shows the subjective percentage of experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval of 0.69 to 0.89 and a P-value of 0.0002, indicating statistical data related to the two doses over a 5-year period.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.